Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $52.3 million.

  • Perspective Therapeutics' Total Non-Current Liabilities fell 1657.17% to $52.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.3 million, marking a year-over-year decrease of 1657.17%. This contributed to the annual value of $50.4 million for FY2024, which is 12181.23% up from last year.
  • According to the latest figures from Q3 2025, Perspective Therapeutics' Total Non-Current Liabilities is $52.3 million, which was down 1657.17% from $44.7 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Total Non-Current Liabilities registered a high of $62.6 million during Q3 2024, and its lowest value of $2.2 million during Q4 2021.
  • In the last 5 years, Perspective Therapeutics' Total Non-Current Liabilities had a median value of $9.9 million in 2023 and averaged $20.8 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 71346.7% in 2023, then tumbled by 1657.17% in 2025.
  • Perspective Therapeutics' Total Non-Current Liabilities (Quarter) stood at $2.2 million in 2021, then grew by 24.81% to $2.8 million in 2022, then skyrocketed by 713.47% to $22.7 million in 2023, then soared by 121.81% to $50.4 million in 2024, then increased by 3.75% to $52.3 million in 2025.
  • Its last three reported values are $52.3 million in Q3 2025, $44.7 million for Q2 2025, and $44.6 million during Q1 2025.